Jazz Pharmaceuticals (JAZZ)
NASDAQ:JAZZ
Holding JAZZ?
Track your performance easily

Jazz Pharmaceuticals (JAZZ) Income Statement

1,489 Followers

Jazz Pharmaceuticals Income Statement

Last quarter (Q3 2024), Jazz Pharmaceuticals's total revenue was $1.05B, an increase of 8.52% from the same quarter last year. In Q3, Jazz Pharmaceuticals's net income was $215.06M. See Jazz Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 3.99B$ 3.83B$ 3.66B$ 3.09B$ 2.36B$ 2.16B
Cost of Revenue
$ 107.24M$ 435.58M$ 540.52M$ -440.76M$ -148.92M$ -127.93M
Gross Profit
$ 3.89B$ 3.40B$ 3.12B$ 2.65B$ 2.21B$ 2.29B
Operating Expense
$ 2.90B$ 2.80B$ 2.61B$ 2.48B$ 1.70B$ 1.50B
Operating Income
$ 648.36M$ 578.58M$ -65.53M$ 170.28M$ 378.07M$ 532.37M
Net Non Operating Interest Income Expense
$ -257.17M$ -289.44M$ -288.24M$ -278.77M$ -99.71M$ -72.26M
Other Income Expense
$ -11.12M$ -10.21M$ -596.81M$ 714.00K$ 2.96M$ 4.09M
Pretax Income
$ 398.66M$ 297.93M$ -372.78M$ -112.84M$ 275.10M$ 454.30M
Tax Provision
$ -66.61M$ -119.91M$ -158.65M$ 216.12M$ 33.52M$ -73.15M
Earnings From Equity Interest Net Of Tax
$ -2.10M$ -3.01M$ -9.92M$ -714.00K$ -2.96M$ -4.09M
Net Income Common Stockholders
$ 463.16M$ 414.83M$ -224.06M$ -329.67M$ 238.62M$ 779.23M
Basic EPS
$ 7.45$ 6.55$ -3.58$ -5.52$ 4.28$ 9.22
Diluted EPS
$ 7.08$ 6.10$ -3.58$ -5.52$ 4.22$ 9.09
Basic Average Shares
$ 249.40M$ 63.29M$ 62.54M$ 59.69M$ 55.71M$ 56.75M
Diluted Average Shares
$ 265.00M$ 72.07M$ 62.54M$ 59.69M$ 56.52M$ 57.55M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 836.99M$ 3.24B$ 3.15B$ 2.04B$ 1.55B$ 1.37B
Net Income From Continuing And Discontinued Operation
$ 463.16M$ 414.83M$ -224.06M$ -329.67M$ 238.62M$ 523.37M
Normalized Income
$ 293.55M-----
Interest Expense
------
EBIT
$ 430.98M$ 587.37M$ -84.54M$ 165.93M$ 374.80M$ 513.40M
EBITDA
$ 922.63M$ 1.23B$ 544.93M$ 718.41M$ 653.05M$ 929.95M
Currency in USD

Jazz Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis